A LEAP TO THE CURE Trademark

Trademark Overview

On Friday, December 20, 2013, a trademark application was filed for A LEAP TO THE CURE with the United States Patent and Trademark Office. The USPTO has given the A LEAP TO THE CURE trademark a serial number of 86977530. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 3, 2022. This trademark is owned by Agilis Biotherapeutics, LLC. The A LEAP TO THE CURE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology research and development for the treatment of Friedreich's ataxia and other life-threatening and rare diseases; development of new technology for others in the field of biotechnology, namely, technology for the treatment of Friedreich's ataxia and other life-threatening and rare diseases
a leap to the cure

General Information

Serial Number86977530
Word MarkA LEAP TO THE CURE
Filing DateFriday, December 20, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 3, 2022
Registration Number4861227
Registration DateTuesday, November 24, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2014

Trademark Statements

Goods and ServicesBiotechnology research and development for the treatment of Friedreich's ataxia and other life-threatening and rare diseases; development of new technology for others in the field of biotechnology, namely, technology for the treatment of Friedreich's ataxia and other life-threatening and rare diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 3, 2022
Primary Code042
First Use Anywhere DateMonday, March 31, 2014
First Use In Commerce DateMonday, March 31, 2014

Trademark Owner History

Party NameAgilis Biotherapeutics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDallas, TX 75225
Party NameAgilis Biotherapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDallas, TX 75225
Party NameAgilis Biotherapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDallas, TX 75225

Trademark Events

Event DateEvent Description
Friday, June 3, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, November 24, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 24, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, October 21, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 20, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 7, 2015STATEMENT OF USE PROCESSING COMPLETE
Monday, September 21, 2015USE AMENDMENT FILED
Wednesday, October 7, 2015DIVISIONAL PROCESSING COMPLETE
Monday, September 21, 2015DIVISIONAL REQUEST RECEIVED
Monday, October 5, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 21, 2015TEAS STATEMENT OF USE RECEIVED
Monday, September 21, 2015TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, March 24, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 6, 2015CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, February 5, 2015EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 3, 2015ASSIGNED TO PETITION STAFF
Thursday, January 22, 2015TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, December 11, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 18, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, October 11, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, October 11, 2014ASSIGNED TO LIE
Friday, September 26, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 25, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 25, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 25, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 27, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 27, 2014NON-FINAL ACTION E-MAILED
Thursday, March 27, 2014NON-FINAL ACTION WRITTEN
Thursday, March 27, 2014ASSIGNED TO EXAMINER
Tuesday, January 7, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 24, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

cure leap threatening biotechnology rare diseases technology other life ataxia treatment development